獸醫骨科植入物市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球獸醫骨科植入物市場價值為6.229億美元，預計到2034年將以8.3%的複合年成長率成長，達到14億美元。這一成長主要得益於全球寵物主人數量的成長，這持續推動了對骨科手術和骨骼整形等先進獸醫服務的需求。獸醫外科技術的進步，尤其是關節鏡等微創技術，也有助於縮短復原時間，提升寵物主人的接受度。

此外，人們對現代動物外科植入物益處的認知不斷提高，為產業參與者創造了新的機會。新興經濟體對動物保健基礎設施的投資進一步促進了市場擴張。此外，正在進行的研發工作重點是開發經濟高效且方便用戶使用的植入物技術，預計將顯著提高已開發市場和發展中市場的採用率。

獸醫骨科手術在治療伴侶動物的肌肉骨骼疾病方面需求尤其強勁。動物損傷和退化性疾病（尤其是關節和韌帶損傷）的發生率持續上升，促使外科植入物的使用量增加。對生物可吸收植入材料的需求也不斷成長，這些材料可在體內自然溶解，無需後續的移除手術。這些材料通常由聚乳酸和聚乙醇酸等聚合物製成，因其安全性、高效性和成本優勢而日益普及。諸如嵌入感測器或藥物釋放塗層的智慧植入物等創新技術也日益受到重視。這些設備有助於監測癒合過程，減少術後感染，進而進一步改善治療效果。

就產品類型而言，市場細分為植入物和器械。植入物類別進一步細分為骨板、關節植入物、骨螺絲和錨、骨針和金屬絲以及其他相關組件。該細分市場在2024年佔據市場主導地位，估值達4.42億美元，預計2034年將成長至9.779億美元。這種主導地位可歸因於人們對寵物骨科護理的認知日益提高，以及先進植入技術的日益普及。

根據動物類型，市場分為小型動物、中型動物和大型動物。小型動物和中型動物細分市場（包括犬、貓和其他體型相似的動物）在2024年佔據了72.6%的市場佔有率，預計到2034年將以8.5%的複合年成長率成長。此細分市場的成長主要得益於全球寵物數量的成長以及骨折和關節疾病等骨科疾病發病率的上升。此外，外科手術治療的可近性提高以及寵物主人投資高品質照護的意願增強，也進一步推動了細分市場的成長。

依應用分析，市場涵蓋脛骨平台平整截骨術 (TPLO)、脛骨結節推進術 (TTA)、關節置換、創傷及其他用途。其中，TPLO 手術仍是主要應用，2024 年市場規模達 1.412 億美元，預計到 2034 年將成長至 3.032 億美元，複合年成長率為 8.1%。該手術尤其以恢復關節穩定性和促進韌帶損傷動物更快康復而聞名。

根據最終用途，市場細分為獸醫醫院和診所以及其他獸醫護理機構。 2024年，獸醫院和診所佔據主導地位，市場價值為5.371億美元，預計到2034年將達到12億美元，複合年成長率為8.5%。設備齊全的診所和醫院的大量存在，加上對綜合獸醫護理日益成長的需求，推動了這一細分市場的發展。診所和醫院也是大多數寵物主人的首選諮詢場所，使其成為整體市場收入的關鍵貢獻者。

從地理分佈來看，北美在2024年佔據全球市場主導地位，市佔率達41.9%。高寵物擁有率、不斷成長的可支配收入以及對高級獸醫護理的強勁需求是推動該地區成長的核心因素。此外，該地區還受益於多家大型獸醫植入物製造商的佈局、簡化的監管途徑以及大量的臨床研究活動，所有這些都有助於該市場的持續擴張。

市場整合程度適中，主要參與者採取收購、合作、產品創新和研發投入等策略來維持競爭優勢。排名前五的公司——DePuy Synthes（強生公司）、Movora（Vimian集團）、Veterinary Instrumentation、Arthrex Vet Systems 和 Rita Leibinger GmbH——合計佔據了全球市場約 60% 的收入。這些公司持續專注於擴大產品組合併進入新市場，以滿足全球日益成長的獸醫骨科護理需求。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
  • 供應商格局
  • 每個階段的增值
  • 影響價值鏈的因素
• 產業衝擊力
  • 成長動力
    • 狗狗骨科疾病發生率不斷上升
    • 獸醫骨科技術的進步
    • 擴大寵物保險覆蓋範圍
    • 提高寵物主人對骨科問題的認知
  • 產業陷阱與挑戰
    • 骨科手術和植入物費用高昂
    • 熟練的獸醫骨科外科醫生數量有限
  • 市場機會
    • 加強植入物製造商和獸醫醫院之間的合作與夥伴關係
    • 新興市場的快速城市化和收入成長
• 成長潛力分析
• 監管格局
  • 北美洲
  • 歐洲
  • 亞太地區
• 技術格局
• 未來市場趨勢
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係與協作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：按產品，2021 年至 2034 年

• 主要趨勢
• 植入物
  • 盤子
    • TPLO板
    • TTA板
    • 創傷板
    • 特種板材
    • 其他板塊
  • 關節植入物
  • 骨螺絲和錨
  • 引腳和電線
  • 其他植入物
• 儀器

第6章：市場估計與預測：依動物類型，2021 年至 2034 年

• 主要趨勢
• 小型和中型動物
  • 狗
  • 貓
  • 其他中小型動物
• 大型動物

第7章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 脛骨平台平整截骨術（TPLO）
• 脛骨結節推進術（TTA）
• 關節置換
  • 髖關節置換術
  • 膝關節置換術
  • 手肘關節置換術
  • 踝關節置換術
• 創傷
• 其他應用

第8章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 獸醫醫院和診所
• 其他最終用途

第9章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• AmerisourceBergen Corporation (Cencora, Inc.)
• Arthrex Vet Systems
• B. Braun
• BlueSAO
• DePuy Synthes (Johnson & Johnson)
• Fusion Implants
• GerVetUSA
• GPC Medical Ltd.
• Integra LifeSciences
• Movora (Vimian Group)
• Narang Medical Limited
• Ortho Max
• Orthomed
• Rita Leibinger
• Veterinary Instrumentation

The Global Veterinary Orthopedic Implants Market was valued at USD 622.9 million in 2024 and is estimated to grow at a CAGR of 8.3% to reach USD 1.4 billion by 2034. This growth is largely influenced by the rising number of pet owners worldwide, which continues to drive demand for advanced veterinary services such as orthopedic procedures and bone contouring. Technological advancements in veterinary surgery-especially minimally invasive techniques like arthroscopy-are also helping to accelerate recovery time, increasing acceptance among pet parents.

Furthermore, greater awareness about the benefits of modern surgical implants in animals has created new opportunities for industry participants. Investments in animal healthcare infrastructure in emerging economies have further reinforced market expansion. Additionally, ongoing R&D efforts are focused on developing cost-effective and user-friendly implant technologies, which are expected to significantly boost adoption rates across both developed and developing markets.

Veterinary orthopedic procedures are in particularly high demand for treating musculoskeletal conditions in companion animals. The prevalence of injuries and degenerative diseases in animals, especially those involving joints and ligaments, continues to rise, prompting increased use of surgical implants. Demand is also climbing for bioabsorbable implant materials that dissolve naturally in the body, eliminating the need for follow-up removal surgeries. These materials, often developed using polymers like polylactic acid and polyglycolic acid, are gaining popularity for their safety, efficiency, and cost advantages. Innovations such as smart implants embedded with sensors or drug-releasing coatings are also becoming more prominent. These devices help monitor healing processes and reduce post-operative infections, further enhancing treatment outcomes.

In terms of product type, the market is segmented into implants and instruments. The implants category is further broken down into plates, joint implants, bone screws and anchors, pins and wires, and other related components. This segment led the market in 2024, reaching a valuation of USD 442 million, and is expected to grow to USD 977.9 million by 2034. This dominance can be attributed to growing awareness around orthopedic care in pets and the increasing availability of sophisticated implant technologies.

By animal type, the market is categorized into small and medium animals and large animals. The small and medium animals segment-which includes dogs, cats, and other similarly sized animals-accounted for 72.6% of the market share in 2024 and is projected to expand at a CAGR of 8.5% through 2034. Growth in this segment is driven by the rising global pet population and the increasing frequency of orthopedic issues, such as fractures and joint disorders. Additionally, enhanced accessibility to surgical treatments and a greater willingness among pet owners to invest in high-quality care are further propelling segment growth.

When analyzed by application, the market includes procedures such as Tibial Plateau Leveling Osteotomy (TPLO), Tibial Tuberosity Advancement (TTA), joint replacement, trauma, and other uses. Among these, TPLO surgery remains a primary application, accounting for USD 141.2 million in 2024, and is projected to grow to USD 303.2 million by 2034, with a CAGR of 8.1%. This procedure is particularly known for restoring joint stability and promoting faster recovery in animals suffering from ligament injuries.

On the basis of end use, the market is segmented into veterinary hospitals and clinics and other veterinary care facilities. In 2024, veterinary hospitals and clinics dominated with a market value of USD 537.1 million, expected to reach USD 1.2 billion by 2034 at a CAGR of 8.5%. The robust presence of well-equipped clinics and hospitals, paired with the growing demand for comprehensive veterinary care, has been instrumental in driving this segment forward. Clinics and hospitals also serve as the initial point of consultation for most pet owners, making them key contributors to overall market revenue.

Geographically, North America led the global market in 2024, holding a share of 41.9%. High levels of pet ownership, rising disposable incomes, and strong demand for advanced veterinary care are core factors fueling regional growth. The region also benefits from the presence of several major veterinary implant manufacturers, streamlined regulatory pathways, and substantial clinical research activities, all of which contribute to the continued expansion of this market.

The market is moderately consolidated, with key players adopting strategies such as acquisitions, partnerships, product innovation, and R&D investments to maintain their competitive edge. The top five companies- DePuy Synthes (Johnson & Johnson), Movora (Vimian Group), Veterinary Instrumentation, Arthrex Vet Systems, and Rita Leibinger GmbH-collectively accounted for approximately 60% of global market revenue. These firms continue to focus on expanding their portfolios and entering new markets to address the growing global need for veterinary orthopedic care.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Animal type
  • 2.2.4 Application
  • 2.2.5 End use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of orthopedic conditions in dogs
    • 3.2.1.2 Advancement in veterinary orthopedic technology
    • 3.2.1.3 Expansion of pet insurance coverage
    • 3.2.1.4 Increasing awareness among pet owners about orthopedic problems
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of orthopedic procedures and implants
    • 3.2.2.2 Limited availability of skilled veterinary orthopedic surgeons
  • 3.2.3 Market opportunities
    • 3.2.3.1 Increasing collaboration and partnership between implant manufacturers and veterinary hospitals
    • 3.2.3.2 Rapid urbanization and income growth in emerging markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Implants
  • 5.2.1 Plates
    • 5.2.1.1 TPLO plates
    • 5.2.1.2 TTA plates
    • 5.2.1.3 Trauma plates
    • 5.2.1.4 Specialty plates
    • 5.2.1.5 Other plates
  • 5.2.2 Joint implants
  • 5.2.3 Bone screws and anchors
  • 5.2.4 Pins and Wires
  • 5.2.5 Other implants
• 5.3 Instruments

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Small and medium animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Other small and medium animals
• 6.3 Large animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Tibial Plateau Leveling Osteotomy (TPLO)
• 7.3 Tibial Tuberosity Advancement (TTA)
• 7.4 Joint replacement
  • 7.4.1 Hip replacement
  • 7.4.2 Knee replacement
  • 7.4.3 Elbow replacement
  • 7.4.4 Ankle replacement
• 7.5 Trauma
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals and clinics
• 8.3 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 AmerisourceBergen Corporation (Cencora, Inc.)
• 10.2 Arthrex Vet Systems
• 10.3 B. Braun
• 10.4 BlueSAO
• 10.5 DePuy Synthes (Johnson & Johnson)
• 10.6 Fusion Implants
• 10.7 GerVetUSA
• 10.8 GPC Medical Ltd.
• 10.9 Integra LifeSciences
• 10.10 Movora (Vimian Group)
• 10.11 Narang Medical Limited
• 10.12 Ortho Max
• 10.13 Orthomed
• 10.14 Rita Leibinger
• 10.15 Veterinary Instrumentation